Rationale of a phase III study comparing a standard cisplatin regimen (mitomycin/ifosfamide/cisplatin) with cisplatin and gemcitabine in non-small cell lung cancer. [electronic resource]
Producer: 19970718Description: S8-31-S8-35 p. digitalISSN:- 0093-7754
- Aged
- Antimetabolites, Antineoplastic -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Cisplatin -- administration & dosage
- Deoxycytidine -- administration & dosage
- Humans
- Ifosfamide -- administration & dosage
- Lung Neoplasms -- drug therapy
- Mitomycin -- administration & dosage
- Ribonucleotide Reductases -- antagonists & inhibitors
- Gemcitabine
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.